BRAINAURORA-B Surges Over 8% in Morning Session as Company Expands National Core Psychiatric Hospital Network

Deep News01-08

BRAINAURORA-B (06681) saw its shares climb 8.46% in morning trading, currently priced at HK$7.82, with a turnover of HK$149 million.

On January 6, BRAINAURORA-B announced that it recently signed significant business cooperation agreements with Peking University Sixth Hospital and Shandong Provincial Mental Health Center (collectively referred to as the "cooperating parties") to jointly advance the research, development, and commercialization of digital therapeutic products for mental health. Furthermore, the "Beijing Key Laboratory for Innovative Transformation of Precision Intelligent Diagnosis and Treatment of Mental Disorders," jointly applied for by the company, Peking University Sixth Hospital, and the National Engineering Research Center for Software Engineering at Peking University, has been officially approved for establishment.

To date, the company has established close commercial cooperation with Beijing Anding Hospital, affiliated with Capital Medical University (a Grade III, Level A psychiatric hospital and the National Center for Mental Disorders), to jointly promote the clinical application of digital therapeutic products for mental health. The latest collaborations with Peking University Sixth Hospital and Shandong Provincial Mental Health Center further expand the company's footprint in core psychiatric hospitals across the nation, building a comprehensive commercialization network that spans from national flagship centers to regional hubs and key specialized hospitals.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment